- Home
- HALO vs EVR Comparison
HALO vs EVR Comparison
Compare HALO & EVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HALO
- EVR
- Stock Information
- Founded
- HALO 1998
- EVR 1995
- Country
- HALO United States
- EVR United States
- Employees
- HALO N/A
- EVR N/A
- Industry
- HALO Biotechnology: Biological Products (No Diagnostic Substances)
- EVR Investment Managers
- Sector
- HALO Health Care
- EVR Finance
- Exchange
- HALO Nasdaq
- EVR Nasdaq
- Market Cap
- HALO 7.4B
- EVR 8.7B
- IPO Year
- HALO N/A
- EVR 2006
- Fundamental
- Price
- HALO $59.97
- EVR $301.36
- Analyst Decision
- HALO Buy
- EVR Buy
- Analyst Count
- HALO 8
- EVR 8
- Target Price
- HALO $65.63
- EVR $294.38
- AVG Volume (30 Days)
- HALO 1.3M
- EVR 589.1K
- Earning Date
- HALO 08-05-2025
- EVR 07-30-2025
- Dividend Yield
- HALO N/A
- EVR 1.11%
- EPS Growth
- HALO 55.40
- EVR 52.07
- EPS
- HALO 3.76
- EVR 11.01
- Revenue
- HALO $1,084,306,000.00
- EVR $3,238,871,000.00
- Revenue This Year
- HALO $25.48
- EVR $10.19
- Revenue Next Year
- HALO $19.78
- EVR $24.33
- P/E Ratio
- HALO $15.95
- EVR $27.40
- Revenue Growth
- HALO 25.64
- EVR 23.41
- 52 Week Low
- HALO $42.01
- EVR $148.63
- 52 Week High
- HALO $70.51
- EVR $324.06
- Technical
- Relative Strength Index (RSI)
- HALO 64.61
- EVR 62.83
- Support Level
- HALO $57.68
- EVR $297.90
- Resistance Level
- HALO $59.38
- EVR $320.65
- Average True Range (ATR)
- HALO 1.32
- EVR 7.36
- MACD
- HALO 0.26
- EVR -1.02
- Stochastic Oscillator
- HALO 70.87
- EVR 46.99
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.
About EVR Evercore Inc.
Evercore is an independent investment bank that derives the majority of its revenue from financial advisory, including merger, acquisition, and restructuring advisory. It also has institutional equities trading, equity underwriting, and investment management businesses that account for around 20% of net revenue. The company was founded in 1996 and went public in 2006. Evercore had approximately 2,380 employees at the end of 2024, and about 75% of its revenue is derived from the United States.